Patrick Zenner, Alan Nies, Robert Friedman, Terri Lomax, Douglas Falkner, Larry Felser, John Tyson, John Guckenheimer, Christoph Lengauer, Mike Shuler | GenomeWeb

Patrick Zenner has joined the board of directors of Exact Sciences of Maynard, Mass., the applied genomics company said last week. Zenner was president and CEO of


before retiring in 2001. He is member of the board of directors for Curagen, Genta, Praecis Pharmaceuticals, and Xoma. Zenner holds an MBA from Fairleigh Dickinson University and a BS in business administration from Creighton University.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.